Used in pharmaceutical research as a key intermediate in the synthesis of proteolysis-targeting chimeras (PROTACs), particularly for targeted protein degradation therapies. Its boronic ester structure enables selective binding to specific enzymes and facilitates the development of novel anticancer and anti-inflammatory agents. Also explored in bioconjugation techniques due to its stability and reactivity under physiological conditions.